Novus Therapeutics Explodes 166% On Anelixis Deal, Capital Raise

Novus Therapeutics (NVUS) has announced it has completed the acquisition of Anelixis Therapeutics, a privately held clinical stage biotech developing a next generation anti-CD40 Ligand (CD40L) antibody as a potential treatment for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases.At the same time, Novus entered into a definitive agreement to sell $108M of non-voting…

Christine Lagarde Has Bigger Problems Than the Euro

(Bloomberg Opinion) — The European Central Bank has a problem, and, no, it is not the exchange rate. The recent appreciation of the euro may have caught all the headlines, but it pales in comparison with the broader challenge the pandemic poses for monetary policy. Rather than simply talking down the currency, the ECB must…

Plant Thieves Scour Forests to Satisfy Foliage-Starved Filipinos

(Bloomberg) — The pandemic has set off a wave of theft in the Philippines. The target? Plants.The government has stepped up monitoring of social media and patrolling of protected natural areas amid reports of traders scouring mountains and forests for plants, including endangered species, to meet a sudden spike in demand from locked-down Filipinos who…

Report: Gilead Sciences And Cancer Treatment Company Immunomedics In $20B Deal

Gilead Sciences Inc. (NASDAQ: GILD) is gearing up to purchase drug innovator Immunomedics Inc. (NASDAQ: IMMU) for a price tag exceeding $20 billion.Per the Wall Street Journal, Immunomedics — a biotech known for breast-cancer treatment Trodelvy — was initially a partner of Gilead before takeover talks began. Terms are expected to be announced Monday. Immunomedics,…

X-Ray Startup Enlists SK Hynix to Disrupt Century-Old Market

(Bloomberg) — Nano-X Imaging Ltd., a startup founded by Israeli investor Ran Poliakine, is joining forces with South Korean chipmaker SK Hynix Inc. to build a machine that could disrupt a century-old X-ray industry.Valued at about $2 billion after listing on Nasdaq last month, Nano-X is seeking to transform a multi-billion-dollar industry that has essentially…

Is Inovio Stock a Buy Right Now? This Is What You Need to Know

This week, one of the key players in the COVID-19 vaccine race took a leap forward.On Tuesday, Inovio Pharmaceuticals (INO) announced that Thermo Fisher Scientific had signed a letter of intent to manufacture its DNA COVID-19 vaccine candidate, INO-4800. Thermo Fisher will be added to a list of partners that includes Richter-Helm Biologics and Ology…

X-Ray Startup Enlists Chipmaker to Disrupt Century-Old Industry

(Bloomberg) — Nano-X Imaging Ltd., a startup founded by Israeli investor Ran Poliakine, is joining forces with South Korean chipmaker SK Hynix Inc. to build a machine that could disrupt a century-old X-ray industry.Valued at about $2 billion after listing on Nasdaq last month, Nano-X is seeking to transform a multi-billion-dollar industry that has essentially…

Nasdaq Futures Resume Declines With Valuation Angst Lingering

(Bloomberg) — U.S. futures on the Nasdaq 100 declined as clouds gathered around a five-month rally that has fattened tech valuations and whipped up speculation in options.September futures on the gauge dropped 0.8% as of 9:56 a.m. in Tokyo. Contracts on the S&P 500 were little changed, erasing a decline of as much as 1.1%.…